• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接合菌对传统和新型抗真菌药物的体外敏感性

In vitro susceptibilities of zygomycetes to conventional and new antifungals.

作者信息

Dannaoui Eric, Meletiadis Joseph, Mouton Johan W, Meis Jacques F G M, Verweij Paul E

机构信息

Department of Medical Microbiology, University Medical Center, St Radboud, PO Box 9101, 6500 HB Nijmegen.

出版信息

J Antimicrob Chemother. 2003 Jan;51(1):45-52. doi: 10.1093/jac/dkg020.

DOI:10.1093/jac/dkg020
PMID:12493786
Abstract

In vitro susceptibilities of 36 zygomycete isolates, belonging to six genera, to itraconazole, posaconazole, voriconazole, terbinafine, amphotericin B and 5-fluorocytosine were determined by using a broth microdilution adaptation of the National Committee for Clinical Laboratory Standards M-38P reference method. The influence of incubation time on MIC values, and the performance of a spectrophotometric method for MIC determination in comparison with the visual reference method, were also evaluated. Amphotericin B was active against most of the isolates. All the isolates were highly resistant to 5-fluorocytosine (MICs > 256 mg/L). Voriconazole was significantly less active than the other drugs with an overall MIC(90) (MIC at which 90% of the isolates were inhibited) of 32 mg/L. In contrast, posaconazole showed good activity (MIC(90) 1 mg/L). A wide range of MICs, from 0.03 to > or =32 mg/L, was obtained for itraconazole and terbinafine. Differences in susceptibility between and within genera were noted. Rhizopus spp. were significantly less susceptible to itraconazole, posaconazole, terbinafine and amphotericin B than Absidia spp., and less susceptible than Mucor spp. to amphotericin B. Terbinafine appeared to be more active against Rhizopus microsporus than against Rhizopus oryzae (geometric mean MIC of 0.15 and 64 mg/L, respectively). The activity of the drugs was dependent on the incubation period. A significant increase in MICs was noted between 24 and 48 h of incubation. On the other hand, the two methods used for MIC determination (visual and spectrophotometric readings) showed good agreement. These results suggest that the zygomycetes are a heterogeneous group for antifungal susceptibility. Some of the conventional and new antifungals are effective in vitro; their efficacies in vivo remain to be determined. The spectrophotometric method appears to be a valuable alternative to the visual method for MIC determination for zygomycetes.

摘要

采用美国国家临床实验室标准委员会M-38P参考方法的肉汤微量稀释法,测定了属于6个属的36株接合菌分离株对伊曲康唑、泊沙康唑、伏立康唑、特比萘芬、两性霉素B和5-氟胞嘧啶的体外敏感性。还评估了孵育时间对最低抑菌浓度(MIC)值的影响,以及与视觉参考方法相比,分光光度法测定MIC的性能。两性霉素B对大多数分离株有活性。所有分离株对5-氟胞嘧啶高度耐药(MIC>256mg/L)。伏立康唑的活性明显低于其他药物,总体MIC(90)(抑制90%分离株的MIC)为32mg/L。相比之下,泊沙康唑显示出良好的活性(MIC(90)为1mg/L)。伊曲康唑和特比萘芬的MIC范围很广,从0.03到≥32mg/L。注意到不同属之间和属内的敏感性差异。根霉属分离株对伊曲康唑、泊沙康唑、特比萘芬和两性霉素B的敏感性明显低于犁头霉属,对两性霉素B的敏感性低于毛霉属。特比萘芬对微小根霉的活性似乎比对米根霉更高(几何平均MIC分别为0.15和64mg/L)。药物的活性取决于孵育期。孵育24至48小时之间,MIC显著增加。另一方面,用于测定MIC的两种方法(视觉读数和分光光度读数)显示出良好的一致性。这些结果表明,接合菌在抗真菌药敏方面是一个异质群体。一些传统和新型抗真菌药物在体外有效;它们在体内的疗效仍有待确定。分光光度法似乎是用于测定接合菌MIC的视觉方法的一种有价值的替代方法。

相似文献

1
In vitro susceptibilities of zygomycetes to conventional and new antifungals.接合菌对传统和新型抗真菌药物的体外敏感性
J Antimicrob Chemother. 2003 Jan;51(1):45-52. doi: 10.1093/jac/dkg020.
2
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.泊沙康唑、氟康唑、伊曲康唑、伏立康唑和两性霉素B对大量临床重要霉菌和酵母菌的体外活性。
Antimicrob Agents Chemother. 2006 Jun;50(6):2009-15. doi: 10.1128/AAC.00163-06.
3
In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.体外抗丝状真菌引起的罕见感染的药敏试验:两性霉素 B、泊沙康唑和安尼白菌素联合药敏试验。
J Antimicrob Chemother. 2012 Aug;67(8):1937-40. doi: 10.1093/jac/dks137. Epub 2012 Apr 25.
4
In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.临床曲霉属和米根霉属物种的体外抗真菌药敏试验。
J Mycol Med. 2016 Mar;26(1):17-21. doi: 10.1016/j.mycmed.2015.12.002. Epub 2016 Feb 4.
5
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).曲霉属临床分离株及实验室筛选的耐药菌株对两性霉素B、伊曲康唑、伏立康唑和泊沙康唑(SCH 56592)体外敏感性的比较研究
J Antimicrob Chemother. 2000 Aug;46(2):229-34. doi: 10.1093/jac/46.2.229.
6
Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.使用分光光度法读数进行曲霉属菌种的体外抗真菌药敏试验
Can J Microbiol. 1999 Oct;45(10):871-4.
7
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.伏立康唑、伊曲康唑和两性霉素B对丝状真菌的体外活性。
J Antimicrob Chemother. 1998 Dec;42(6):741-5. doi: 10.1093/jac/42.6.741.
8
Rapid susceptibility testing of medically important zygomycetes by XTT assay.采用XTT法对医学上重要的接合菌进行快速药敏试验。
J Clin Microbiol. 2006 Feb;44(2):553-60. doi: 10.1128/JCM.44.2.553-560.2006.
9
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.针对念珠菌属,将氟康唑、伊曲康唑、泊沙康唑和伏立康唑的视觉24小时和分光光度法48小时最低抑菌浓度(MIC)与CLSI参考微量稀释法MIC进行比较:一项合作研究。
J Clin Microbiol. 2005 Sep;43(9):4535-40. doi: 10.1128/JCM.43.9.4535-4540.2005.
10
Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different media.使用两种不同培养基评估两性霉素B和制霉菌素对30株接合菌的抗真菌后效应(PAFE)。
J Antimicrob Chemother. 2003 Jul;52(1):65-70. doi: 10.1093/jac/dkg285. Epub 2003 May 29.

引用本文的文献

1
Necrotizing orbital infections: A comprehensive review.坏死性眼眶感染:全面综述
Saudi J Ophthalmol. 2025 Jun 25;39(2):128-140. doi: 10.4103/sjopt.sjopt_87_25. eCollection 2025 Apr-Jun.
2
Comparison of the Filamentous Fungi Library v4.0 MALDI Biotyper Platform vs MSI-2 performance for identifying filamentous fungi from liquid cultures.丝状真菌文库v4.0基质辅助激光解吸电离生物分型平台与MSI-2在从液体培养物中鉴定丝状真菌方面的性能比较。
J Clin Microbiol. 2025 Mar 12;63(3):e0137124. doi: 10.1128/jcm.01371-24. Epub 2025 Jan 31.
3
Trans-kingdom fungal pathogens infecting both plants and humans, and the problem of azole fungicide resistance.
感染植物和人类的跨界真菌病原体以及唑类杀菌剂抗性问题。
Front Microbiol. 2024 Feb 12;15:1354757. doi: 10.3389/fmicb.2024.1354757. eCollection 2024.
4
sp. nov. and sp. nov. Isolated from Clinical Samples.从临床样本中分离出的新种和新种。
J Fungi (Basel). 2024 Jan 13;10(1):64. doi: 10.3390/jof10010064.
5
A Retrospective Observational Study on the Comparison of Different Diagnostic Modalities of Post-COVID Mucormycosis.一项关于新冠后毛霉菌病不同诊断方式比较的回顾性观察研究。
Cureus. 2023 Nov 16;15(11):e48925. doi: 10.7759/cureus.48925. eCollection 2023 Nov.
6
In vitro combination with doxycycline plus antifungals against clinical Mucorales pathogens.体外联合多西环素和抗真菌药物治疗临床毛霉病病原体。
Braz J Microbiol. 2023 Dec;54(4):2597-2602. doi: 10.1007/s42770-023-01167-z. Epub 2023 Nov 7.
7
Epidemiology, Modern Diagnostics, and the Management of Mucorales Infections.毛霉目感染的流行病学、现代诊断方法及管理
J Fungi (Basel). 2023 Jun 12;9(6):659. doi: 10.3390/jof9060659.
8
Rhino-Orbital Cerebral Mucormycosis: A Fatal Evolution.鼻眶脑毛霉菌病:致命的病程发展
Cureus. 2023 Apr 19;15(4):e37837. doi: 10.7759/cureus.37837. eCollection 2023 Apr.
9
Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents.毛霉菌病:真菌感染的隐藏谜团,可能的诊断、治疗和新治疗药物的研发。
Eur J Med Chem. 2023 Jan 15;246:115010. doi: 10.1016/j.ejmech.2022.115010. Epub 2022 Dec 10.
10
Entomophthoromycosis Presenting as a Nasal Mass.以鼻肿物形式表现的虫霉病
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):1207-1209. doi: 10.1007/s12070-020-02211-2. Epub 2021 Jan 2.